Merck & Co., Inc. (MRK) stock
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30239% above fair value
$143.37−1.09 (-0.75%)
Close on Nov 17, 2026Market cap $353.72BP/E 114.7Yield 2.29%
Merck operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Merck's operating cash flow for the twelve months ending Jun 30, 2026 was $19.97B, up 7.7% year over year. For fiscal 2025 it was $16.47B, down 23.3% from the year before. Over ten years it grew 2.8% a year on average. The highest annual figure on record is $21.47B in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.47B | -23.3% |
| FY2024 | Dec 31, 2024 | $21.47B | +65.1% |
| FY2023 | Dec 31, 2023 | $13.01B | -31.9% |
| FY2022 | Dec 31, 2022 | $19.10B | +45.5% |
| FY2021 | Dec 31, 2021 | $13.12B | +72.3% |
| FY2020 | Dec 31, 2020 | $7.62B | -14.3% |
| FY2019 | Dec 31, 2019 | $8.88B | -18.7% |
| FY2018 | Dec 31, 2018 | $10.92B | +69.3% |
| FY2017 | Dec 31, 2017 | $6.45B | -37.8% |
| FY2016 | Dec 31, 2016 | $10.38B | -17.2% |
| FY2015 | Dec 31, 2015 | $12.54B | +56.9% |
| FY2014 | Dec 31, 2014 | $7.99B | -31.4% |
| FY2013 | Dec 31, 2013 | $11.65B | +16.3% |
| FY2012 | Dec 31, 2012 | $10.02B | -19.1% |
| FY2011 | Dec 31, 2011 | $12.38B | +14.4% |
| FY2010 | Dec 31, 2010 | $10.82B | +219.0% |
| FY2009 | Dec 31, 2009 | $3.39B | -48.4% |
| FY2008 | Dec 31, 2008 | $6.57B | -6.1% |
| FY2007 | Dec 31, 2007 | $7.00B | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.37B | +63.1% |
| Q1 FY2026 | Mar 31, 2026 | $3.92B | +56.7% |
| Q4 FY2025 | Dec 31, 2025 | $2.86B | -17.2% |
| Q3 FY2025 | Sep 30, 2025 | $7.82B | -15.8% |
| Q2 FY2025 | Jun 30, 2025 | $3.29B | -41.6% |
| Q1 FY2025 | Mar 31, 2025 | $2.50B | -19.1% |
| Q4 FY2024 | Dec 31, 2024 | $3.45B | +1302.4% |
| Q3 FY2024 | Sep 30, 2024 | $9.29B | +20.4% |
| Q2 FY2024 | Jun 30, 2024 | $5.64B | +52.2% |
| Q1 FY2024 | Mar 31, 2024 | $3.09B | +130.8% |
| Q4 FY2023 | Dec 31, 2023 | $246.00M | -94.4% |
| Q3 FY2023 | Sep 30, 2023 | $7.72B | +37.8% |
| Q2 FY2023 | Jun 30, 2023 | $3.70B | -13.9% |
| Q1 FY2023 | Mar 31, 2023 | $1.34B | -71.9% |
| Q4 FY2022 | Dec 31, 2022 | $4.43B | -13.1% |
| Q3 FY2022 | Sep 30, 2022 | $5.60B | +16.8% |
| Q2 FY2022 | Jun 30, 2022 | $4.30B | +116.2% |
| Q1 FY2022 | Mar 31, 2022 | $4.76B | +284.0% |
| Q4 FY2021 | Dec 31, 2021 | $5.10B | +49.4% |
| Q3 FY2021 | Sep 30, 2021 | $4.80B | +203.2% |
| Q2 FY2021 | Jun 30, 2021 | $1.99B | +3.8% |
| Q1 FY2021 | Mar 31, 2021 | $1.24B | +75.4% |
| Q4 FY2020 | Dec 31, 2020 | $3.41B | +1332.8% |
| Q3 FY2020 | Sep 30, 2020 | $1.58B | -62.6% |
| Q2 FY2020 | Jun 30, 2020 | $1.92B | -37.8% |
| Q1 FY2020 | Mar 31, 2020 | $707.00M | -47.1% |
| Q4 FY2019 | Dec 31, 2019 | $238.00M | -93.4% |
| Q3 FY2019 | Sep 30, 2019 | $4.23B | +51.3% |
| Q2 FY2019 | Jun 30, 2019 | $3.08B | -8.8% |
| Q1 FY2019 | Mar 31, 2019 | $1.34B | +15.7% |
| Q4 FY2018 | Dec 31, 2018 | $3.59B | -10.6% |
| Q3 FY2018 | Sep 30, 2018 | $2.79B | – |
| Q2 FY2018 | Jun 30, 2018 | $3.38B | +2.0% |
| Q1 FY2018 | Mar 31, 2018 | $1.16B | +303.8% |
| Q4 FY2017 | Dec 31, 2017 | $4.02B | +10.7% |
| Q3 FY2017 | Sep 30, 2017 | -$1.17B | -139.4% |
| Q2 FY2017 | Jun 30, 2017 | $3.32B | – |
| Q1 FY2017 | Mar 31, 2017 | $286.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $3.63B | – |
| Q3 FY2016 | Sep 30, 2016 | $2.97B | – |
See a number that looks wrong?